Suchergebnisse - "Chamberlain, James M"

PubPharm (8)

1

Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial

enthalten in: Annals of emergency medicine | 2022

von Coralic, Z. | Kapur, J. | Olson, K. | +3

CommentIn: Ann Emerg Med. 2022 Dec;80(6):572-573. - PMID 36404003

2

Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status Epilepticus

enthalten in: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society | 2022

von Zehtabchi, S. | Silbergleit, R. | Chamberlain, J. | +6

3

A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposure

enthalten in: Clinical and translational science | 2021

von Sathe, A. | Brundage, R. | Ivaturi, V. | +6

4

Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus

enthalten in: Journal of clinical pharmacology | 2021

von Sathe, A. | Mishra, U. | Ivaturi, V. | +12

5

The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus

enthalten in: Epilepsia | 2020

von Sathe, A. | Elm, J. | Cloyd, J. | +10

6

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT) : a double-blind, responsive-adaptive, randomised controlled trial

enthalten in: Lancet (London, England) | 2020

von Chamberlain, J. | Kapur, J. | Shinnar, S. | +117

CommentIn: Lancet. 2020 Apr 11;395(10231):1172-1173. - PMID 32203690

7

Lessons from the Established Status Epilepticus Treatment Trial

enthalten in: Epilepsy & behavior : E&B | 2019

von Cock, H. | Coles, L. | Elm, J. | +9

8

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

enthalten in: The New England journal of medicine | 2019

von Kapur, J. | Elm, J. | Chamberlain, J. | +111

CommentIn: N Engl J Med. 2019 Nov 28;381(22):2171-2172. - PMID 31774965

1
[1]